Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 9 studies | 20% ± 4% | |
endothelial cell | 8 studies | 20% ± 4% | |
macrophage | 6 studies | 22% ± 5% | |
naive B cell | 5 studies | 19% ± 3% | |
oligodendrocyte | 5 studies | 24% ± 6% | |
epithelial cell | 4 studies | 28% ± 5% | |
memory B cell | 4 studies | 18% ± 5% | |
classical monocyte | 3 studies | 20% ± 2% | |
neuron | 3 studies | 25% ± 8% | |
basal cell | 3 studies | 28% ± 12% | |
dendritic cell | 3 studies | 18% ± 1% | |
glutamatergic neuron | 3 studies | 40% ± 21% | |
astrocyte | 3 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6275.66 | 1445 / 1445 | 100% | 27.40 | 183 / 183 |
uterus | 100% | 7173.32 | 170 / 170 | 100% | 20.37 | 459 / 459 |
breast | 100% | 6064.65 | 459 / 459 | 100% | 35.19 | 1117 / 1118 |
brain | 100% | 6992.74 | 2637 / 2642 | 100% | 33.19 | 705 / 705 |
prostate | 100% | 6255.71 | 245 / 245 | 100% | 26.22 | 501 / 502 |
thymus | 100% | 6403.16 | 653 / 653 | 100% | 30.56 | 603 / 605 |
bladder | 100% | 7073.05 | 21 / 21 | 100% | 18.81 | 502 / 504 |
lung | 100% | 5637.88 | 576 / 578 | 100% | 23.81 | 1151 / 1155 |
intestine | 100% | 8119.63 | 966 / 966 | 99% | 19.49 | 522 / 527 |
stomach | 100% | 5150.69 | 359 / 359 | 99% | 21.64 | 283 / 286 |
skin | 100% | 5871.68 | 1808 / 1809 | 99% | 30.97 | 467 / 472 |
pancreas | 99% | 3690.43 | 326 / 328 | 99% | 23.21 | 177 / 178 |
kidney | 100% | 4122.20 | 89 / 89 | 98% | 25.96 | 886 / 901 |
ovary | 100% | 7022.64 | 180 / 180 | 97% | 16.66 | 418 / 430 |
adrenal gland | 100% | 4021.22 | 257 / 258 | 97% | 21.46 | 222 / 230 |
liver | 99% | 2143.69 | 223 / 226 | 90% | 10.81 | 364 / 406 |
adipose | 100% | 5695.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7356.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.58 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.95 | 29 / 29 |
spleen | 100% | 7549.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.72 | 1 / 1 |
muscle | 100% | 4947.83 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 6469.67 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 2886.31 | 816 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0006302 | Biological process | double-strand break repair |
GO_0007143 | Biological process | female meiotic nuclear division |
GO_0048477 | Biological process | oogenesis |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005777 | Cellular component | peroxisome |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_1905762 | Molecular function | CCR4-NOT complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0004540 | Molecular function | RNA nuclease activity |
GO_0003674 | Molecular function | molecular_function |
GO_0003723 | Molecular function | RNA binding |
Gene name | MARF1 |
Protein name | Meiosis regulator and mRNA stability factor 1 (Limkain-b1) Meiosis regulator and mRNA stability factor 1 Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1) |
Synonyms | KIAA0430 LKAP |
Description | FUNCTION: Essential regulator of oogenesis required for female meiotic progression to repress transposable elements and preventing their mobilization, which is essential for the germline integrity. Probably acts via some RNA metabolic process, equivalent to the piRNA system in males, which mediates the repression of transposable elements during meiosis by forming complexes composed of RNAs and governs the methylation and subsequent repression of transposons. Also required to protect from DNA double-strand breaks (By similarity). . |
Accessions | Q9Y4F3 ENST00000549219.1 F8VVB8 ENST00000632465.1 [Q9Y4F3-4] H0YIB6 F8VRS5 G8JLP4 ENST00000540441.6 ENST00000552553.5 ENST00000633837.1 ENST00000621511.2 [Q9Y4F3-1] ENST00000551742.5 [Q9Y4F3-5] ENST00000396368.8 [Q9Y4F3-1] ENST00000548025.5 [Q9Y4F3-4] ENST00000633811.1 ENST00000632628.1 [Q9Y4F3-5] ENST00000633549.1 ENST00000631398.1 ENST00000551878.1 |